Published in Endocrinol Metab Clin North Am on June 01, 2011
Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol (2012) 1.20
Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits? Hypertension (2011) 0.84
Pediatric endocrine hypertension. Indian J Endocrinol Metab (2011) 0.82
Primary aldosteronism in 2011: Towards a better understanding of causation and consequences. Nat Rev Endocrinol (2011) 0.82
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature (2012) 4.26
Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab (2004) 2.56
Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. Chest (2013) 1.88
Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study. Hypertension (2010) 1.85
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens (2003) 1.70
Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab (2005) 1.68
Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med (2008) 1.68
Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study. J Clin Endocrinol Metab (2011) 1.64
Aldosterone assays: an urgent need for improvement. Clin Chem (2006) 1.46
Resistant hypertension: incidence, prevalence, and prognosis. Circulation (2012) 1.46
The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab (2012) 1.23
Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med (2010) 1.15
Diagnosis and management of primary aldosteronism: an updated review. Ann Med (2013) 1.13
Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab (2009) 1.07
Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism. Hypertension (2014) 1.03
Primary aldosteronism--careful investigation is essential and rewarding. Mol Cell Endocrinol (2004) 1.02
Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes. DNA Cell Biol (2011) 1.01
Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens (2005) 0.99
ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab (2014) 0.97
Treatment of hypertension in the emergency department. J Am Soc Hypertens (2011) 0.96
Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin Chem (2009) 0.94
Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. J Clin Endocrinol Metab (2015) 0.94
First Brazilian position on resistant hypertension. Arq Bras Cardiol (2012) 0.94
Reninoma: the importance of renal vein renin ratios for lateralisation and diagnosis. Am J Nephrol (2013) 0.94
Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens (2008) 0.91
Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study. J Clin Endocrinol Metab (2014) 0.90
Aldosterone and cardiovascular disease. Curr Probl Cardiol (2009) 0.89
Primary aldosteronism. Best Pract Res Clin Endocrinol Metab (2003) 0.88
Laboratory investigation of primary aldosteronism. Clin Biochem Rev (2010) 0.88
Aldosterone, dietary salt, and renal disease. Hypertension (2006) 0.88
Plasma renin and aldosterone measurements in low renin hypertensive states. Trends Endocrinol Metab (2005) 0.86
Hypertensive crisis: forget the numbers. J Hypertens (2012) 0.85
Efficacy of an olmesartan medoxomil-based treatment algorithm in patients stratified by age, race, or sex. J Clin Hypertens (Greenwich) (2010) 0.84
Monogenic mineralocorticoid hypertension. Best Pract Res Clin Endocrinol Metab (2006) 0.84
Simultaneous measurement of aldosterone and cortisol by high-performance liquid chromatography-tandem mass spectrometry: application to dehydration-rehydration studies. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.83
Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? J Clin Endocrinol Metab (2010) 0.83
A systematic review and meta-analysis of thiazide-induced hyponatraemia: time to reconsider electrolyte monitoring regimens after thiazide initiation? Br J Clin Pharmacol (2015) 0.83
The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J Hypertens (2004) 0.81
Aldosterone excess or escape: Treating resistant hypertension. J Clin Hypertens (Greenwich) (2009) 0.79
Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocrinol Metab (2010) 0.79
Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. J Clin Endocrinol Metab (2011) 0.79
Primary aldosteronism: from genesis to genetics. Trends Endocrinol Metab (2003) 0.78
Salt and aldosterone: a concert of bad effects. Hypertension (2010) 0.78
Aldosterone excess, hypertension, and chromosome 7p22: evidence continues to mount. Hypertension (2007) 0.78
The alpha-actinin-3 r577x polymorphism and physical performance in soccer players. J Sports Med Phys Fitness (2015) 0.78
Treatment of resistant hypertension. J Hypertens (2010) 0.78
Renin angiotensin system blockage associates with insertion/deletion polymorphism of angiotensin-converting enzyme in patients with hypertensive emergency. DNA Cell Biol (2013) 0.77
Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients. J Clin Endocrinol Metab (2011) 0.77
The aldosterone-renin ratio and primary aldosteronism. Mayo Clin Proc (2002) 0.77
Effect of atenolol on aldosterone/renin ratio calculated by both plasma Renin activity and direct Renin concentration in healthy male volunteers. J Clin Endocrinol Metab (2010) 0.77
Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma. J Hypertens (2013) 0.76
Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration. J Clin Endocrinol Metab (2011) 0.76
Aldosterone and metabolic dysfunction: an unresolved issue. Hypertension (2009) 0.76
Elevated serum interleukin 6 levels in normotensive individuals with familial hyperaldosteronism type 1. Hypertension (2009) 0.76
Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. Clin Endocrinol (Oxf) (2004) 0.76
Testing of Junctional Tourniquets by Military Medics to Control Simulated Groin Hemorrhage. J Spec Oper Med (2015) 0.75
Beyond brachial pressure effect. Curr Hypertens Rep (2008) 0.75
Hyperreninemic hypertension following presumed abdominal trauma. Nat Rev Nephrol (2011) 0.75
Response. Chest (2013) 0.75
Can mutations in ion channel genes cause endocrine dysfunction? J Hypertens (2006) 0.75
[Secondary systemic arterial hypertension]. J Bras Nefrol (2010) 0.75
Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extension. J Rheumatol (2011) 0.75
Calibrators for measuring aldosterone by liquid chromatography-tandem mass spectrometry. Clin Chim Acta (2011) 0.75
No evidence for coding region mutations in the retinoblastoma-associated Kruppel-associated box protein gene (RBaK) causing familial hyperaldosteronism type II. Clin Endocrinol (Oxf) (2006) 0.75
Urinary clonidine suppression testing for the diagnosis of pheochromocytoma. J Hypertens (2015) 0.75
The utility of renal venous renin studies in selection of patients with renal artery stenosis for angioplasty: a retrospective study. J Hypertens (2015) 0.75